| Structure | Chemical Name | CAS | MF |
|
ANTI-MOUSE CD3 BIOTIN CONJUGATE
|
|
|
|
|
ANTI-MOUSE IGG+IGA+IGM (H+L)
|
|
|
|
|
ANTI-MOUSE SHH C-TERMINAL PEPTIDE
|
|
|
|
|
ANTI-M-CALPAIN (DOMAIN III/IV)
|
|
|
|
|
ANTI-MEKK1
|
|
|
|
|
ANTI-MOUSE B LYMPHOCYTE SUBSET ANTIBODY COCKTAIL, WITH ISOTYPE CONTROL
|
|
|
|
|
ANTI-MOUSE ID1
|
|
|
|
|
ANTI-MMP-14
|
|
|
|
|
ANTI-MOUSE CD14, FITC
|
|
|
|
|
ANTI-MOUSE CD45RC, PE
|
|
|
|
|
ANTI-MOUSE CD104
|
|
|
|
|
ANTI-MOUSE CD11C, BIOTIN
|
|
|
|
|
ANTI-MOUSE I-EK, FITC
|
|
|
|
|
ANTI-MMP-21, HINGE REGION
|
|
|
|
ANTIMONY D-TARTRATE
|
|
C12H12O18Sb2
|
|
|
ANTI-MGLUR8
|
|
|
|
|
ANTI-MOUSE CD19, PERCP-CY5.5
|
|
|
|
|
ANTIMICROBIC VIAL CNVT
|
|
|
|
|
ANTI-MEASLES, NUCLEOPROTEIN FITC
|
|
|
|
|
ANTI-MOUSE V-BETA 3 TCR
|
|
|
|
|
ANTI-MOUSE CD45R/B220, PERCP-CY5.5
|
|
|
|
|
ANTI-MOUSE CXCL15 BIOTIN
|
|
|
|
|
ANTI-MUC-2 GLYCOPROTEIN
|
|
|
|
|
ANTI-MOUSE ALBUMIN, HRP
|
|
|
|
|
ANTI-MOUSE P33
|
|
|
|
|
ANTI-MOUSE LINEAGE PANEL, BIOTIN
|
|
|
|
|
ANTI-MATRIX METALLOPROTEINASE-23 (MMP-23), C-TERMINAL
|
|
|
|
|
ANTI-MOUSE IGG CY5
|
|
|
|
|
ANTI-MOUSE 4-1BB, PE
|
|
|
|
|
ANTI-MYOSIN, HEART
|
|
|
|
|
ANTI-MOUSE MCP-1
|
|
|
|
|
ANTI-MOUSE EPITHELIAL CELLS AND ACTIVATED LEUKOCYTES
|
|
|
|
|
HAMSTER ANTI-MOUSE CD28
|
|
|
|
|
ANTI-MMP-18 (AB-1), XENOPUS
|
|
|
|
|
ANTI-MOUSE IGF-I
|
|
|
|
|
ANTI-MMP-14, CATALYTIC DOMAIN
|
|
|
|
|
ANTI-MOUSE IGG (WHOLE MOLECULE)-FITC
|
|
|
|
|
ANTI-MOUSE IG, DIGOX CONJUGATE
|
|
|
|
|
ANTI-MOUSE CD3 EPSILON CHAIN, PE
|
|
|
|
|
ANTI-MUPP1
|
|
|
|
|
ANTI-MOUSE CD45RC
|
|
|
|
|
ANTI-MOUSE IGG - F(AB)2, HEAVY AND LIGHT CHAINS PHYCOPROBE R-PE LABELED
|
|
|
|
|
ANTI-MKK4
|
|
|
|
|
ANTI-MOUSE LY-6A.2
|
|
|
|
|
ANTI-MOUSE RANTES
|
|
|
|
|
ANTI-MATRIX METALLOPROTEINASE-19, HINGE REGION RABBIT
|
|
|
|
|
ANTI-MATRIX METALLOPROTEINASE-21, PROPEPTIDE REGION
|
|
|
|
|
ANTI-MOUSE CD223
|
|
|
|
|
ANTI-MBP AA 82-87
|
|
|
|
|
ANTI-MOUSE LY-49I, BIOTIN
|
|
|
|
ANTIMONY(III) IODIDE
|
7790-44-5
|
I3Sb
|
|
|
ANTI-MOUSE IG, TEXAS RED-LINKED WHOLE AB
|
|
|
|
ANTIMONY(III) POTASSIUM OXIDE (+) TARTRATE 0.5 HYDRATE
|
|
C12H13KO19Sb2
|
|
|
ANTI-MOUSE TRAF1
|
|
|
|
|
ANTI-MOUSE IGM SEPHAROSE(R) 4B
|
|
|
|
|
ANTI-MHC CLASS II (RT-1B) ANTIGEN (RAT)
|
|
|
|
|
ANTI-MAFA
|
|
|
|
|
ANTI-MOUSE I-AK, BIOTIN
|
|
|
|
|
ANTI-MKP2
|
|
|
|
|
ANTI-MHC TSH-2B,P, MOUSE
|
|
|
|
|
ANTI-MOUSE CD49B, PE
|
|
|
|
|
ANTI-MOUSE LY-51 (6C3/BP-1 ANTIGEN)
|
|
|
|
|
ANTI-MOUSE CD28 EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
|
ANTI-MOUSE YSI SPA SCINTILLATION BEADS
|
|
|
|
|
ANTI-MEK1 (PSER298) RABBIT PAB
|
|
|
|
|
ANTI-MOTILIN (CANINE)
|
|
|
|
|
ANTI-MOUSE CD120A BIOTIN
|
|
|
|
|
ANTI-MOUSE CD95 LIGAND, BIOTIN
|
|
|
|
|
ANTI-MARCKS
|
|
|
|
|
ANTI-MOUSE HTLV-II, P19 CLONE 78/6.18.07
|
|
|
|
|
ANTI-MOUSE CD102, FITC
|
|
|
|
|
ANTI-MACROPHAGES (MOUSE)-CLONE ER-TR9 BIOTINYLATED
|
|
|
|
|
ANTI-MOUSE EPHA8 EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-MONOGLYCERIDE LIPASE
|
|
|
|
|
ANTI-MOUSE IGM (MU) FITC
|
|
|
|
|
ANTI-MCH RECEPTOR TYPE 2 (HUMAN)
|
|
|
|
|
ANTI-MOUSE CD34 BIOTIN
|
|
|
|
|
ANTI-MOUSE IL-4, ALEXA FLUOR(R) 647
|
|
|
|
|
ANTI-MOUSE IL-11 R-ALPHA EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
|
ANTI-MOUSE APP (ABNT)
|
|
|
|
|
ANTI-MOUSE CD49A
|
|
|
|
|
ANTI-MOUSE H-2KB/H-2DB
|
|
|
|
|
ANTI-MOUSE SHH C-TERMINAL PEPTIDE, BIOTIN
|
|
|
|
Potassium antimonyl tartrate sesquihydrate
|
28300-74-5
|
C8H4O12Sb2.3H2O.2K
|
|
|
ANTI-MACROPHAGE INFLAMMATORY PROTEIN-MIP II (MIP II), VIRAL
|
|
|
|
|
ANTI-MOUSE IGG (FAB FRAGMENT), HRP
|
|
|
|
|
ANTI-MOUSE CD3ZETA
|
|
|
|
|
ANTI-MOUSE CD74 (LI)
|
|
|
|
|
ANTI-MOUSE NCAM-2 EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-MOUSE V-BETA 14 TCR, FITC
|
|
|
|
|
ANTI-MOUSE CD43, BIOTIN
|
|
|
|
|
ANTI-MOUSE IL-13 R-ALPHA2 EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-MUSCARINIC M1 RECEPTOR (AA 451-460)
|
|
|
|
|
ANTI-MOUSE H-2DQ/H-2LQ, BIOTIN
|
|
|
|
|
ANTI-MOUSE IG, F(AB)2, FLUORESCEIN, FITC CONJUGATE
|
|
|
|
|
ANTI-MONKEY IGG (HEAVY AND LIGHT CHAINS), FITC
|
|
|
|
|
ANTI-MOUSE IMMUNOGLOBULINS IGG, IGA, AND IGM RHODAMINE CONJUGATED
|
|
|
|
|
ANTI-MOUSE IFN-GAMMA
|
|
|
|
|
ANTI-MYELOID PRECURSOR CELLS (CD 34-LIKE), MOUSE
|
|
|
|
|
ANTI-MYELOPEROXIDASE, PE
|
|
|